Skip to main content
Log in

A novel hemizygous loss-of-function mutation in ADGRG2 causes male infertility with congenital bilateral absence of the vas deferens

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

Cystic fibrosis transmembrane conductance regulator (CFTR) and adhesion G protein-coupled receptor G2 (ADGRG2) have been identified as the main pathogenic genes in congenital bilateral absence of the vas deferens (CBAVD), which is an important cause of obstructive azoospermia. This study aimed to identify the disease-causing gene in two brothers with CBAVD from a Chinese consanguineous family and reveal the intracytoplasmic sperm injection (ICSI) outcomes in these patients.

Methods

Whole-exome sequencing and Sanger sequencing were used to identify the candidate pathogenic genes. Real-time polymerase chain reaction, immunohistochemistry, and immunofluorescence were used to assess the expression of the mutant gene. Moreover, the ICSI results from both patients were retrospectively reviewed.

Results

A novel hemizygous loss-of-function mutation (c.G118T: p.Glu40*) in ADGRG2 was identified in both patients with CBAVD. This mutation is absent from the human genome databases and causes an early translational termination in the third exon of ADGRG2. Expression analyses showed that both the ADGRG2 mRNA and the corresponding protein were undetectable in the proximal epididymal tissue of ADGRG2-mutated patients. ADGRG2 expression was restricted to the apical membranes of non-ciliated epithelia in human efferent ducts, which was consistent with a previous report in mice. Both ADGRG2-mutated patients had normal spermatogenesis and had successful clinical outcomes following ICSI.

Conclusions

Our study verifies the pathogenic role of ADGRG2 in X-linked CBAVD and broadens the spectrum of ADGRG2 mutations. In addition, we found positive ICSI outcomes in the two ADGRG2-mutated CBAVD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wosnitzer MS, Goldstein M. Obstructive azoospermia. Urol Clin North Am. 2014;41:83–95.

    Article  Google Scholar 

  2. Yu J, Chen Z, Ni Y, Li Z. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum Reprod. 2012;27:25–35.

    Article  CAS  Google Scholar 

  3. Chen H, Ruan YC, Xu WM, Chen J, Chan HC. Regulation of male fertility by CFTR and implications in male infertility. Hum Reprod Update. 2012;18:703–13.

    Article  CAS  Google Scholar 

  4. Li H, Wen Q, Li H, Zhao L, Zhang X, Wang J, et al. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) in Chinese patients with congenital bilateral absence of vas deferens. J Cyst Fibros. 2012;11:316–23.

    Article  CAS  Google Scholar 

  5. Yuan P, Liang ZK, Liang H, Zheng LY, Li D, Li J, et al. Expanding the phenotypic and genetic spectrum of Chinese patients with congenital absence of vas deferens bearing CFTR and ADGRG2 alleles. Andrology. 2019;7:329–40.

    Article  CAS  Google Scholar 

  6. Elborn JS. Cystic fibrosis. Lancet. 2016;388:2519–31.

    Article  CAS  Google Scholar 

  7. Lee CH, Wu CC, Wu YN, Chiang HS. Gene copy number variations in Asian patients with congenital bilateral absence of the vas deferens. Hum Reprod. 2009;24:748–55.

    Article  CAS  Google Scholar 

  8. Wu YN, Chen KC, Wu CC, Lin YH, Chiang HS. SLC9A3 affects vas deferens development and associates with Taiwanese congenital bilateral absence of the vas deferens. Biomed Res Int. 2019;2019:3562719.

    PubMed  PubMed Central  Google Scholar 

  9. Patat O, Pagin A, Siegfried A, Mitchell V, Chassaing N, Faguer S, et al. Truncating mutations in the adhesion G protein-coupled receptor G2 gene ADGRG2 cause an X-linked congenital bilateral absence of vas deferens. Am J Hum Genet. 2016;99:437–42.

    Article  CAS  Google Scholar 

  10. Yang B, Wang J, Zhang W, Pan H, Li T, Liu B, et al. Pathogenic role of ADGRG2 in CBAVD patients replicated in Chinese population. Andrology. 2017;5:954–7.

    Article  CAS  Google Scholar 

  11. Khan MJ, Pollock N, Jiang H, Castro C, Nazli R, Ahmed J, et al. X-linked ADGRG2 mutation and obstructive azoospermia in a large Pakistani family. Sci Rep. 2018;8:16280.

    Article  Google Scholar 

  12. Pagin A, Bergougnoux A, Girodon E, Reboul MP, Willoquaux C, Kesteloot M, et al. Novel ADGRG2 truncating variants in patients with X-linked congenital absence of vas deferens. Andrology. 2019 Dec 17. https://doi.org/10.1111/andr.12744.

  13. Obermann H, Samalecos A, Osterhoff C, Schroder B, Heller R, Kirchhoff C. HE6, a two-subunit heptahelical receptor associated with apical membranes of efferent and epididymal duct epithelia. Mol Reprod Dev. 2003;64:13–26.

    Article  CAS  Google Scholar 

  14. Hamann J, Aust G, Arac D, Engel FB, Formstone C, Fredriksson R, et al. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. Pharmacol Rev. 2015;67:338–67.

    Article  CAS  Google Scholar 

  15. Davies B, Baumann C, Kirchhoff C, Ivell R, Nubbemeyer R, Habenicht UF, et al. Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility. Mol Cell Biol. 2004;24:8642–8.

    Article  CAS  Google Scholar 

  16. Zhang DL, Sun YJ, Ma ML, Wang YJ, Lin H, Li RR, et al. Gq activity- and beta-arrestin-1 scaffolding-mediated ADGRG2/CFTR coupling are required for male fertility. eLife. 2018;7:e33432.

  17. Lu S, Cui Y, Li X, Zhang H, Liu J, Kong B, et al. Association of cystic fibrosis transmembrane-conductance regulator gene mutation with negative outcome of intracytoplasmic sperm injection pregnancy in cases of congenital bilateral absence of vas deferens. Fertil Steril. 2014;101:1255–60.

    Article  CAS  Google Scholar 

  18. Llabador MA, Pagin A, Lefebvre-Maunoury C, Marcelli F, Leroy-Martin B, Rigot JM, et al. Congenital bilateral absence of the vas deferens: the impact of spermatogenesis quality on intracytoplasmic sperm injection outcomes in 108 men. Andrology. 2015;3:473–80.

    Article  CAS  Google Scholar 

  19. Wu H, Li W, He X, Liu C, Fang Y, Zhu F, et al. NovelCFAP43 andCFAP44 mutations cause male infertility with multiple morphological abnormalities of the sperm flagella (MMAF). Reprod BioMed Online. 2019;38:769–78.

    Article  CAS  Google Scholar 

  20. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.

    Article  CAS  Google Scholar 

  21. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.

    Article  CAS  Google Scholar 

  22. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2.

    Article  CAS  Google Scholar 

  23. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995;332:1475–80.

    Article  CAS  Google Scholar 

  24. de Souza DAS, Faucz FR, Pereira-Ferrari L, Sotomaior VS, Raskin S. Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling. Andrology. 2018;6:127–35.

    Article  Google Scholar 

  25. Oppenheimer EH, Esterly JR. Observations on cystic fibrosis of the pancreas. V. Developmental changes in the male genital system. J Pediatr. 1969;75:806–11.

    Article  CAS  Google Scholar 

  26. Patrizio P, Zielenski J. Congenital absence of the vas deferens: a mild form of cystic fibrosis. Mol Med Today. 1996;2:24–31.

    Article  CAS  Google Scholar 

  27. Bieth E, Hamdi SM, Mieusset R. Genetics of the congenital absence of the vas deferens. Hum Genet. 2020.  https://doi.org/10.1007/s00439-020-02122-w.

  28. Gaillard DA, Carre-Pigeon F, Lallemand A. Normal vas deferens in fetuses with cystic fibrosis. J Urol. 1997;158:1549–52.

    Article  CAS  Google Scholar 

  29. Kirchhoff C, Osterhoff C, Samalecos A. HE6/GPR64 adhesion receptor co-localizes with apical and subapical F-actin scaffold in male excurrent duct epithelia. Reproduction. 2008;136:235–45.

    Article  CAS  Google Scholar 

  30. Wang YY, Lin YH, Wu YN, Chen YL, Lin YC, Cheng CY, et al. Loss of SLC9A3 decreases CFTR protein and causes obstructed azoospermia in mice. PLoS Genet. 2017;13:e1006715.

    Article  Google Scholar 

  31. Kuo YM, Duncan JL, Westaway SK, Yang H, Nune G, Xu EY, et al. Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. Hum Mol Genet. 2005;14:49–57.

    Article  CAS  Google Scholar 

  32. Da Silva N, Pietrement C, Brown D, Breton S. Segmental and cellular expression of aquaporins in the male excurrent duct. Biochim Biophys Acta. 1758;2006:1025–33.

    Google Scholar 

  33. Hihnala S, Kujala M, Toppari J, Kere J, Holmberg C, Hoglund P. Expression of SLC26A3, CFTR and NHE3 in the human male reproductive tract: role in male subfertility caused by congenital chloride diarrhoea. Mol Hum Reprod. 2006;12:107–11.

    Article  CAS  Google Scholar 

  34. Xu WM, Chen J, Chen H, Diao RY, Fok KL, Dong JD, et al. Defective CFTR-dependent CREB activation results in impaired spermatogenesis and azoospermia. PLoS One. 2011;6:e19120.

    Article  CAS  Google Scholar 

  35. Xu WM, Shi QX, Chen WY, Zhou CX, Ni Y, Rowlands DK, et al. Cystic fibrosis transmembrane conductance regulator is vital to sperm fertilizing capacity and male fertility. Proc Natl Acad Sci U S A. 2007;104:9816–21.

    Article  CAS  Google Scholar 

  36. Li CY, Jiang LY, Chen WY, Li K, Sheng HQ, Ni Y, et al. CFTR is essential for sperm fertilizing capacity and is correlated with sperm quality in humans. Hum Reprod. 2010;25:317–27.

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by the National Natural Science Foundation of China (81901541 and 81971441), Natural Science Foundation of Anhui Province (1908085QH313 and 1908085MH244), Special Foundation for Development of Science and Technology of Anhui Province (2017070802D150 and YDZX20183400004194), Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT310002), and Shanghai Municipal Science and Technology Major Project (2017SHZDZX01).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiaojin He or Yunxia Cao.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethics approval

This research was approved by the Ethical Review Board of The First Affiliated Hospital of Anhui Medical University.

Consent to participate

All subjects participating in this study signed their informed consents.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM1

(PDF 428 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, H., Gao, Y., Ma, C. et al. A novel hemizygous loss-of-function mutation in ADGRG2 causes male infertility with congenital bilateral absence of the vas deferens. J Assist Reprod Genet 37, 1421–1429 (2020). https://doi.org/10.1007/s10815-020-01779-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-020-01779-6

Keywords

Navigation